PREDICTION OF HBSAG LOSS USING HBSAG DECLINE AFTER LONG-TERM VIROLOGICAL RESPONSE TO NUCLEOS(T)IDE ANALOGUE THERAPY FOR CHRONIC HEPATITIS B

被引：0
|
作者：
Zoutendijk, Roeand [1 ]
Hansen, Bettina E. [1 ]
van Vuuren, Anneke J. [1 ]
Boucher, Charles A. [1 ]
Janssen, Harry L. [1 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
381
引用
收藏
页码：509A / 509A
页数：1
相关论文
共 50 条
  • [31] The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy
    Coffin, C. S.
    Rezaeeaval, M.
    Pang, J. X.
    Alcantara, L.
    Klein, P.
    Burak, K. W.
    Myers, R. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (11-12) : 1262 - 1269
  • [32] KINETICS AND PREDICTION OF HBSAG SEROCLEARANCE DURING LONG- TERM TREATMENT WITH NUCLEOS( T) IDE ANALOGUES IN PATIENTS WITH CHRONIC HEPATITIS
    Young, Yim Sun
    Hyun, Sarah Jaewon
    Song, Seoyoung
    Seo, Yeon Seok
    Lee, Young-Sun
    Yim, Hyung Joon
    Kim, Ji Hoon
    Jung, Young Kul
    Kang, Seong Hee
    Kim, Taehyung
    Yeon, Jong Eun
    Choi, Eunho
    HEPATOLOGY, 2024, 80 : S251 - S251
  • [33] Long Term HBsAg Responses to Peg-Interferon Alpha-2b in HBeAg Negative Chronic Hepatitis B Patients Developing Clinical Relapse after Stopping Long-Term Nucleos(t)ide Analogue Therapy
    Kumar, Karan
    Jindal, Ankur
    Gupta, Ekta
    Trehanpati, Nirupma
    Shasthry, Saggere M.
    Maiwall, Rakhi
    Arora, Vinod
    Bhardwaj, Ankit
    Kumar, Guresh
    Kumar, Manoj
    Sarin, Shiv K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2024, 14 (01)
  • [34] HIGH VIROLOGICAL RELAPSE RATE AFTER NUCLEOS(T)IDE ANALOGUE DISCONTINUATION IN CHRONIC HEPATITIS B
    Chi, H.
    Arends, P.
    Wong, D. K.
    Yim, C.
    Hansen, B. E.
    Janssen, H. L. A.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S436 - S436
  • [35] STOPPING LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY BEFORE HBsAg LOSS IN HBeAg NEGATIVE CHB PATIENTS: FOLLOW-UP OF LONG TERM RESPONDERS
    Petersen, J.
    Buggisch, P.
    Hinrichsen, H.
    Berg, T.
    Wedemeyer, H.
    Cornberg, M.
    Stoehr, A.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S313 - S314
  • [36] Interruption of nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B - a new concept to achieve HBsAg reduction?
    Siederdissen, C. Hoener Zu
    Rinker, F.
    Falk, C. S.
    Filmann, N.
    Maasoumy, B.
    Deterding, K.
    Port, K.
    Herrmann, E.
    Wedemeyer, H.
    Manns, M. P.
    Kraft, A. R.
    Cornberg, M.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 50 - 50
  • [37] RETRACTION: Finite versus Indefinite Nucleos(t)ide Analogue Therapy of Patients with Chronic Hepatitis B Exhibiting Negative HBsAg Levels after Treatment
    Sun, H.
    Liu, Y.
    Zhang, Y.
    BIOMED RESEARCH INTERNATIONAL, 2024, 2024
  • [38] Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
    Kim, Soon Sun
    Cheong, Jae Youn
    Cho, Sung Won
    GUT AND LIVER, 2011, 5 (03) : 278 - 287
  • [39] Trend patterns of HBsAg kinetics in chronic hepatitis B patients during nucleos(t)ide analogue therapy based on ARMA models
    Yu, Hsien-Chung
    Huo, Wen-Wei
    Lin, Kung-Hung
    Sun, Wei-Chih
    Lee, Ching-Nun
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2023, 122 (06) : 458 - 469
  • [40] Mapping the HBsAg immune phenotype to predict HBsAg decline in chronic hepatitis B in patients receiving nucleot(s)ide analogue therapy
    Lim, L. Y.
    Yuen, L.
    Hammond, R.
    Angus, P. W.
    Thompson, A. J.
    Patterson, S. J.
    Leary, T.
    Yi, P.
    Thomas, H.
    Locarnini, S.
    Walsh, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 154 - 154
12345